| abstract |
The present disclosure relates to a drug delivery device. The drug delivery device (100) includes a drug container (102) containing a medical fluid, wherein the medical fluid contains insulin glargine dissolved therein, and a hollow needle (120) defining an elongated interior space , the medicinal solution is dispensable from the medicinal container (102) through the elongated interior space, wherein the needle (120) is at least partially made of chloride resistant steel, wherein the elongated interior The space is in fluid communication with the drug container in the storage or pre-delivery state, particularly if there is no significant exchange of drug fluid within the interior space for a period of at least 1 hour. |